Billets de Michelle Dawson

Billet publié sur Twitter/X le 27/01/2021 11:20

Retour aux billets Billet précédent Billet suivant
Twitter/X Essai clinique clinicaltrials.gov Extrait cité dans le billet Question posée par Dawson dans le billet Lien intégré au billet Termes sur l’autisme
Ouvrir le billet original

Infos sur le lien intégré au billet

Essai clinique

University of Missouri, Kansas City (2023). Amitriptyline for Repetitive Behaviors in Autism Spectrum Disorders. ClinicalTrials.gov. University of Missouri, Kansas City.

Plus d’infos

Liens cités structurés

1 ressource citée

Essai clinique Récupéré Publication clinicaltrials.gov

University of Missouri, Kansas City (2023). Amitriptyline for Repetitive Behaviors in Autism Spectrum Disorders. ClinicalTrials.gov. University of Missouri, Kansas City.

Date de publication
01/11/2023
Identifiant
NCT04725383
Auteurs
University of Missouri, Kansas City
Source
ClinicalTrials.gov
Type de référence
clinical_trial
Éditeur
University of Missouri, Kansas City
Source de métadonnées
clinicaltrials.gov

Résumé

The investigators will recruit 30 children and adolescents (15 per group x 2 groups) aged 6 to 17 years with ASD and significant repetitive behaviors that cause problems to them and to others around them. Subjects will be randomized to either amitriptyline (AMI), dosed flexibly according to response and tolerability with a maximum dose of 100mg per day or 1.5mg/kg/day, in divided doses to minimize side effects, or placebo in look-alike capsules, for 10 weeks. Rating scales will be used to measure outcomes.

Ouvrir la source